
Teladoc Health, Inc. (NYSE:TDOC - Free Report) - Research analysts at William Blair cut their Q1 2026 earnings per share (EPS) estimates for shares of Teladoc Health in a research note issued on Tuesday, July 29th. William Blair analyst R. Daniels now forecasts that the health services provider will earn ($0.33) per share for the quarter, down from their prior forecast of ($0.32). The consensus estimate for Teladoc Health's current full-year earnings is ($1.16) per share. William Blair also issued estimates for Teladoc Health's Q2 2026 earnings at ($0.21) EPS, Q3 2026 earnings at ($0.19) EPS and Q4 2026 earnings at ($0.19) EPS.
Teladoc Health (NYSE:TDOC - Get Free Report) last announced its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. The business had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%. The company's quarterly revenue was down 1.6% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.38) EPS.
Several other research firms have also issued reports on TDOC. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Jefferies Financial Group reduced their price target on Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Evercore ISI raised their price target on Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research report on Wednesday, July 9th. Bank of America reduced their price target on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 28th. Finally, Truist Financial dropped their price objective on Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a report on Tuesday, May 27th. Twelve analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, Teladoc Health presently has an average rating of "Hold" and a consensus price target of $9.76.
View Our Latest Stock Analysis on TDOC
Teladoc Health Trading Down 1.1%
NYSE:TDOC traded down $0.08 during trading hours on Friday, reaching $6.90. The company's stock had a trading volume of 5,209,661 shares, compared to its average volume of 7,018,050. The firm has a 50-day simple moving average of $7.71 and a 200-day simple moving average of $8.48. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. Teladoc Health has a 1 year low of $6.35 and a 1 year high of $15.21. The firm has a market capitalization of $1.22 billion, a price-to-earnings ratio of -5.79 and a beta of 1.76.
Insider Activity at Teladoc Health
In other Teladoc Health news, insider Carlos Nueno sold 3,958 shares of Teladoc Health stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $27,151.88. Following the completion of the transaction, the insider owned 17,645 shares in the company, valued at approximately $121,044.70. The trade was a 18.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Fernando M. Rodrigues sold 4,174 shares of Teladoc Health stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total value of $28,842.34. The disclosure for this sale can be found here. Insiders have sold 18,656 shares of company stock worth $128,189 over the last ninety days. 0.58% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in TDOC. Golden State Wealth Management LLC increased its holdings in shares of Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after purchasing an additional 1,690 shares in the last quarter. National Bank of Canada FI increased its holdings in shares of Teladoc Health by 79.4% in the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock worth $28,000 after purchasing an additional 1,581 shares in the last quarter. SVB Wealth LLC bought a new stake in shares of Teladoc Health in the 1st quarter worth $37,000. Sterling Capital Management LLC increased its holdings in shares of Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock worth $42,000 after purchasing an additional 4,101 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of Teladoc Health in the 1st quarter worth $50,000. Hedge funds and other institutional investors own 76.82% of the company's stock.
Teladoc Health Company Profile
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
See Also

Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.